Market Tracker

07/20 10:39am ET

Albireo Pharma Inc (NASDAQ:ALBO)

26.50
Delayed Data
As of 10:16am ET
 -0.85 / -3.11%
Today’s Change
9.69
Today|||52-Week Range
37.69
+49.46%
Year-to-Date
No recent news for Albireo Pharma Inc.

Today’s Trading

Previous close27.35
Today’s open27.69
Day’s range26.50 - 27.69
Volume5,091
Average volume (3 months)29,774
Market cap$232.3M
Dividend yield--
Data as of 10:16am ET, 07/20/2017

Growth & Valuation

Earnings growth (last year)+4.42%
Earnings growth (this year)+40.08%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales1.93
Price/Book4.66

Competitors

 Today’s
change
Today’s
% change
OVIDOvid Therapeutics In...+0.20+2.12%
SBBPStrongbridge Biophar...-0.39-5.89%
IMDZImmune Design Corp+0.10+1.09%
PPHMPeregrine Pharmaceut...+0.02+0.38%
Data as of 10:24am ET, 07/20/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$1.00
Annual revenue (last year)$11.4M
Annual profit (last year)-$16.4M
Net profit margin-143.88%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Ron Cooper
Chief Operating Officer
Jan Peter Mattsson
Corporate headquarters
Boston, Massachusetts

Forecasts